InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
5,505.00
(
-0.71%
)
US TECH 100
19,000.00
(
-0.94%
)
Dow Jones
40,287.53
(
-0.93%
)
Brent Oil
81.88
(
0.00%
)
Bitcoin
66,633.34
(
-0.13%
)
Post# of 438
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biotech_researcher

Send PM Follow Ignore
Followers 84
Posts 12487
Boards Moderated 0
Alias Born 07/25/2008

biotech_researcher

Re: None

Friday, 09/21/2018 7:58:38 PM

Friday, September 21, 2018 7:58:38 PM

Post# of 438
Aratana Therapeutics Inc (NASDAQ:PETX) CEO Peter Steven St sold 75,000 shares of the business's stock in a transaction that occurred on Friday, September 21st. The shares were sold at an average price of $6.06, for a total value of $454,500.00. Following the completion of the sale, the chief executive officer now owns 574,233 shares of the company's stock, valued at $3,479,851.98. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up